Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SALE OF COMMON STOCK (Details Narrative)

SALE OF COMMON STOCK (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands									1 Months Ended				2 Months Ended	3 Months Ended		12 Months Ended
	Apr. 19, 2021	Feb. 09, 2021	Feb. 08, 2021	Jan. 11, 2021	Sep. 04, 2020	Apr. 08, 2020	Feb. 07, 2020	Nov. 14, 2019	May 10, 2021	Aug. 31, 2020	Jul. 31, 2020	Feb. 28, 2020	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019
Proceeds from the exercise of warrants														$ 2	$ 7,474
Number of options granted														12,774,310
Net proceeds														$ 108,680	16,679
Preferred stock deemed dividend															1,260
Warrant deemed dividend															$ 451
Series B Convertible Preferred Stock [Member]
Number of shares converted (in shares)															5,313
Series A Convertible Preferred Stock [Member]
Issuance of Series A Convertible preferred stock and common stock warrants (in shares)																7,938
Warrant One [Member]
Exercised price (in dollars per share)														$ 0.50
Net proceeds											$ 1,200
Warrants from Feb 2020 Financing [Member]
Number of exercised warrants													10,800,000
Exercised price (in dollars per share)										$ 0.57			$ 0.57		$ 0.57
Net proceeds										$ 1,300
Proceeds from the exercise of warrants													$ 6,200
Number of shares issued, value										$ 2,200
Warrants from Nov 2019 Financing [Member]
Number of exercised warrants															2,300,000
Exercised price (in dollars per share)													$ 0.57		$ 0.57
Proceeds from the exercise of warrants															$ 1,300
Warrant deemed dividend															$ 500
Sales Agreement [Member] \| Alliance Global Partners [Member] \| Subsequent Event [Member]
Net proceeds									$ 3,200
Number of shares issued (in shares)									2,600,000
Underwriting Agreement [Member] \| Alliance Global Partners [Member]
Sale of stock, price (in dollars per share)												$ 1.10
Percentage of underwriting discount								7.00%				7.00%
Underwriting discount												$ 1,100
Net proceeds												14,800
Offering expenses								$ 500				$ 100
Number of shares issued (in shares)												14,550,000
Net proceeds								$ 7,900
Underwriting Agreement [Member] \| Alliance Global Partners [Member] \| Class A Units [Member]
Sale of stock, price (in dollars per share)								$ 1.94
Issuance of common stock and common stock warrants (in shares)								547,420
Number of common shares per unit								1
Issue of shares at discount								$ 600
Underwriting Agreement [Member] \| Alliance Global Partners [Member] \| Class B Units [Member]
Sale of stock, price (in dollars per share)								$ 1,000
Issuance of Series A Convertible preferred stock and common stock warrants (in shares)								7,938
Underwriting Agreement [Member] \| Class A Unit [Member]
Number of units sold							3,837,000
Sale of stock, price (in dollars per share)							$ 0.57
Underwriting Agreement [Member] \| Class B Unit [Member]
Number of units sold							5,313
Sale of stock, price (in dollars per share)							$ 1,000
Conversion price (in dollars per share)							$ 0.57
Number of shares of common stock convertible							1,754.386
Number of warrants issued							1,754.386
Exercised price (in dollars per share)							$ 0.57
Warrant term							5 years
Underwriting Agreement [Member] \| Series A Convertible Preferred Stock [Member] [Default Label] \| Alliance Global Partners [Member] \| Class B Units [Member]
Preferred stock deemed dividend								$ 2,500
Underwriting Agreement [Member] \| IPO [Member] \| Class B Unit [Member] \| Alliance Global Partners [Member]
Underwriting discount							$ 500
Net proceeds							6,500
Offering expenses							500
Preferred stock deemed dividend							$ 1,300
Underwriting Agreement [Member] \| Warrants [Member] \| Alliance Global Partners [Member]
Exercised price (in dollars per share)								$ 1.94
Warrants expiration period								5 years
Underwriting Agreement [Member] \| Warrants [Member] \| Alliance Global Partners [Member] \| Class B Units [Member]
Number of warrants to purchase to common stock per unit								515.464
Underwriting Agreement [Member] \| Common Warrants [Member] \| Alliance Global Partners [Member]
Exercised price (in dollars per share)								$ 1.94
Value of securities traded to trigger exercise of warrants								$ 9,000
Warrants expiration period								12 months
Underwriting Agreement [Member] \| Common Warrants [Member] \| Alliance Global Partners [Member] \| Class B Units [Member]
Number of warrants to purchase to common stock per unit								257.732
Underwriting Agreement [Member] \| Alliance Global Partners [Member]
Sale of stock, price (in dollars per share)			$ 1.20	$ 0.80
Underwriting discount		$ 4,900		$ 2,800
Net proceeds		65,000		36,900
Offering expenses		$ 100		$ 300
Number of shares issued (in shares)			58,333,334	50,000,000
Cash fee		7.00%		7.00%
Sales Agreement [Member] \| Alliance Global Partners [Member]
Number of units sold														9,500
Offering price at-the-market offerings						$ 50,000
Commission to agent						3.00%
Gross proceeds from stock issuance														$ 7,000
Sales Agreement [Member] \| ATM [Member]
Offering price per agreement					$ 100,000
Sales Agreement [Member] \| ATM [Member] \| Subsequent Event [Member]
Number of shares issued (in shares)									2,600,000
Net proceeds									$ 3,200
Offering price per agreement	$ 170,000